Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 10, 2023

SELL
$6.28 - $9.85 $628 - $985
-100 Reduced 50.0%
100 $0
Q4 2022

Feb 14, 2023

SELL
$6.09 - $7.93 $2,436 - $3,172
-400 Reduced 66.67%
200 $1,000
Q3 2022

Oct 26, 2022

BUY
$4.58 - $9.21 $1,190 - $2,394
260 Added 76.47%
600 $4,000
Q2 2022

Aug 10, 2022

BUY
$7.06 - $23.63 $211 - $708
30 Added 9.68%
340 $2,000
Q1 2022

May 13, 2022

BUY
$21.6 - $27.79 $6,696 - $8,614
310 New
310 $7,000
Q1 2020

Apr 01, 2020

SELL
$12.98 - $30.25 $2,596 - $6,050
-200 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$20.64 - $25.67 $4,128 - $5,134
200 New
200 $5,000

Others Institutions Holding BHC

About Bausch Health Companies Inc.


  • Ticker BHC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 361,728,000
  • Market Cap $2.67B
  • Description
  • Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...
More about BHC
Track This Portfolio

Track Nelson, Van Denburg & Campbell Wealth Management Group, LLC Portfolio

Follow Nelson, Van Denburg & Campbell Wealth Management Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nelson, Van Denburg & Campbell Wealth Management Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nelson, Van Denburg & Campbell Wealth Management Group, LLC with notifications on news.